Breaking News

Financial Report: PAREXEL

January 30, 2013

Revenues up 25% in the quarter


2Q Revenues: $483.1 million (+25%)

2Q Earnings: $21.3 million (+65%)

YTD Revenues: $945.7 million (+26%)

YTD Earnings: $36.4 million (+62%)

Comments: Clinical Research Services (CRS) revenue was $320.6 million in the quarter, up 29%. PAREXEL Consulting & Medical Communications Services (PCMS) revenues were $49.3 million, up 28%. Perceptive Informatics (PI) revenues were $101.4 million, up 12%. Newly-acquired Liquent, Inc. contributed $0.4 million to revenue in the quarter. Backlog at the end of December 2012 was approximately $4.5 billion, up 21%.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks